This project is based on the hypothesis that NK cells, activated either in vivo or ex vivo (and subsequently transferred back into the recipient), might constitute an effective therapy of disseminated cancer. The applicant will therefore test and compare the anti-neoplastic effect of activated NK cells in rat models of disseminated breast cancer at different stages of progression (i.e., early, late, and dormant metastases). This will be done by: 1) measuring the accumulation of both endogenous NK cells and adoptively transferred IL-2-activated NK (A-NK) cells into early and late MADB106 mammary carcinoma metastases, and the extent of NK cell attack and destruction of such lesions; 2) determining the ability of endogenous NK cells and adoptively transferred A-NK cells to localize into dormant versus active metastases of the EMS-86 mammary carcinoma, and analyzing whether activation of endogenous NK cells and/or the adoptive transfer of A-NK cells during the dormant state of metastatic breast cancer disease can prevent the recurrence of metastatic growth. Furthermore, studies will be carried out to evaluate both the adhesion molecules involved in localization of endogenous NK cells and adoptively transferred A-NK cells into metastases and the mechanisms behind the anti-neoplastic effects mediated by NK/A-NK cells. The investigator believes that these studies will provide information and insights that might be translatable to new clinical strategies for improving treatment of women with metastatic breast cancer and identify the size and/or stage of metastases most likely to respond to immunotherapeutic approaches based on NK cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA065998-05
Application #
2856381
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Hecht, Toby T
Project Start
1995-01-01
Project End
2000-12-31
Budget Start
1999-01-01
Budget End
2000-12-31
Support Year
5
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Ribeiro Jr, U; Basse, P H; Rosenstein, M et al. (1997) Retention of adoptively transferred interleukin-2-activated natural killer cells in tumor tissue. Anticancer Res 17:1115-23
Chambers, W H; Bozik, M E; Brissette-Storkus, S C et al. (1996) NKR-P1+ cells localize selectively in Rat 9L gliosarcomas but have reduced cytolytic function. Cancer Res 56:3516-25
Donskov, F; Basse, P H; Hokland, M (1996) Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue. Nat Immun 15:134-46